Immune checkpoint inhibitor-induced diabetes mellitus in metastatic NSCLC: a case report with extended follow-up and management considerations - Poll - MDSpire

Immune checkpoint inhibitor-induced diabetes mellitus in metastatic NSCLC: a case report with extended follow-up and management considerations

  • By

  • Daniele Nova

  • Gabriele Giuseppe Pagliari

  • Sara Mambrito

  • Diego Luigi Cortinovis

  • Stefania Canova

  • July 17, 2026

Share

Original Source(s)

Immune checkpoint inhibitor-induced diabetes mellitus in metastatic NSCLC: a case report with extended follow-up and management considerations

  • by Daniele Nova, Gabriele Giuseppe Pagliari, Sara Mambrito, Diego Luigi Cortinovis, Stefania Canova

  • July 17, 2026

Related Content

Predictive modeling for survival-related outcomes in lung cancer patients with brain metastases: a mini-review

Ancestry informative genetic variants associated with tobacco metabolic and detoxification capacity measured by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) among smokers

First-line penpulimab combined with anlotinib achieves complete response in an elderly patient with occult lung squamous cell carcinoma: a case report